Letter: Assessing the prognostic value of agile 3+and agile 4 scores in predicting chronic kidney disease development in patients with metabolic dysfunction-associated steatotic liver disease

被引：0
|
作者：
Qin, Zhenzhi [1 ,2 ]
Xu, Yan [1 ]
机构：
[1] Qingdao Univ, Affiliated Hosp, Dept Nephrol, 16 Jiangsu Rd, Qingdao 266003, Peoples R China
[2] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2024年 / 60卷 / 11-12期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1111/apt.18287
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
This article is linked to Jung et al paper. To view this article, visit
引用
收藏
页码：1633 / 1634
页数：2
相关论文
共 50 条
  • [31] Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Increased Risk of Kidney Cancer: A Nationwide Study
    Oh, Juyeon
    Kim, Beom Kyung
    Yoon, Jin-Ha
    Lee, Hyung Ho
    Park, Heejoo
    Lee, Jian
    Park, Youngsun
    Yun, Byungyoon
    Chung, Jinsoo
    CANCERS, 2024, 16 (18)
  • [32] Identification of Risk Factors Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease in Psoriatic Patients
    Kucuk, Kirley
    Moreno, Christophe
    Nijmi, Hassane
    Daoud, Mathieu
    Mintoff, Dillon
    Willaert, Fabienne
    Benhadou, Farida
    DERMATOLOGY, 2025, 241 (01)
  • [33] Alterations of the duodenal mucosal microbiome in patients with metabolic dysfunction-associated steatotic liver disease
    Ren, Mengting
    Pan, Hanghai
    Zhou, Xinxin
    Yu, Mosang
    Ji, Feng
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [34] Circulating levels of FNDC4 are reduced in patients with metabolic dysfunction-associated steatotic liver disease
    Neira, G.
    Becerril, S.
    Valenti, V.
    Catalan, V.
    Gomez-Ambrosi, J.
    Escalada, J.
    Fruhbeck, G.
    Rodriguez, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54
  • [35] Risk factors for hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
    Liew, Ian Yang
    Phua, Hwee Pin
    Lim, Wei Yen
    Chow, Angela
    Loo, Xiu Ying
    Sim, Kevin
    Lee, Eng Sing
    Yew, Kuo Chao
    JOURNAL OF HEPATOLOGY, 2024, 80 : S497 - S498
  • [36] MASKED HYPERTENSION IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE - AN UNDERESTIMATED RISK?
    Martin, Anna
    Lang, Sonja
    Demir, Muenevver
    Goeser, Tobias
    Steffen, Hans-Michael
    Kasper, Philipp
    JOURNAL OF HYPERTENSION, 2024, 42
  • [37] COMPARATIVE DIAGNOSTIC ACCURACY OF AGILE SCORES AND COMMON NON-INVASIVE TESTS IN DETECTING ADVANCED LIVER FIBROSIS IN PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
    Ismail, Mona
    Kuriry, Hadi
    Ismail, Marwa
    HEPATOLOGY, 2024, 80 : S665 - S666
  • [38] Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease
    Jamialahmadi, Oveis
    De Vincentis, Antonio
    Tavaglione, Federica
    Malvestiti, Francesco
    Li-Gao, Ruifang
    Mancina, Rosellina M.
    Alvarez, Marcus
    Gelev, Kyla
    Maurotti, Samantha
    Vespasiani-Gentilucci, Umberto
    Rosendaal, Frits Richard
    Kozlitina, Julia
    Pajukanta, Paeivi
    Pattou, Francois
    Valenti, Luca
    Romeo, Stefano
    NATURE MEDICINE, 2024, 30 (12) : 3614 - 3623
  • [39] Recruitment of Minority Patients in Metabolic Dysfunction-Associated Steatotic Liver Disease Clinical Trials
    Park, Sarah
    Wollstein, Yael
    Hutchison, Alan L.
    Paul, Sonali
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1393 - S1393
  • [40] Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
    Lucia Brodosi
    Michele Stecchi
    Francesca Marchignoli
    Elisabetta Lucia
    Lucia Magnani
    Valeria Guarneri
    Maria Letizia Petroni
    Giulio Marchesini
    Loris Pironi
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 28
12345